Paulina Lange

Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease

John Koreth, Haesook T. Kim, Kyle T. Jones et al. · Blood · 2016 · 206 citations · Full text

TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline <i>BRCA</i> Carriers With HER2-Negative Breast Cancer (the INFORM trial)

Nadine Tung, Banu Arun, Michele R. Hacker et al. · Journal of Clinical Oncology · 2020 · 125 citations · Full text

The addition of sirolimus to the graft‐versus‐host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial

Philippe Armand, Haesook T. Kim, Marie-Michèle Sainvil et al. · British Journal of Haematology · 2016 · 56 citations · Full text

The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034)

Faina Nakhlis, Gabrielle M. Baker, Melissa Pilewskie et al. · Annals of Surgical Oncology · 2020 · 42 citations

Intraoperative Consultation, Surgical Oncology, Medicine +8

Abstract GS2-10: Nimbus: A phase 2 trial of nivolumab plus ipilimumab for patients with hypermutated her2-negative metastatic breast cancer (MBC)

Romualdo Barroso‐Sousa, Tianyu Li, Sangeetha M. Reddy et al. · Cancer Research · 2022 · 36 citations

Breast Oncology, Immunology, Pathology +19